# An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer

> clinical trial · VERIFIED · 2026-08-27

Status: ACTIVE_NOT_RECRUITING · Sponsor: Montefiore Medical Center · Condition: Resectable Stage IIA to IIIB Non-small Cell Lung Cancer

- Company: Montefiore Medical Center
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT05500092

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.